business inside

Cardiometabolic Disease Market 2017: Analysis and Information for Every Aspact of the Industry

Press Release   •   Feb 03, 2017 17:31 IST

Cardiometabolic disease, commonly known as Reaven’s syndrome, is characterized by a group of abnormalities and symptoms that include abdominal obesity, high-blood pressure, poor cholesterol profile (LDL), dyslipidemia (high serum triglycerides), and high plasma glucose. Individuals suffering from cardiometabolic syndrome are prone to a number of diseases such as type 2 diabetes, coronary artery disease (CAD), cardiovascular disease (CVD), stroke, heart failure, and hypertension. Both genetic and environmental conditions can be responsible for the development of cardiometabolic diseases. Various symptoms related to cardiometabolic diseases include central obesity or apple-shaped adiposity, high blood pressure, fatty liver, sleep apnea, erectile dysfunction, and polycystic ovarian syndrome.

Request a Brochure of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=73

Global Cardiometabolic Market: Key Segmentations

Based on the treatments, the global cardiometabolic disease market can be segmented into ACE inhibitors, diuretics, Glucophage, and liposuctions. Angiotensin-converting-enzyme (ACE) inhibitors are a group of drugs, primarily used for the treatment of hypertension and heart failures. They help reduce blood vessel tension and buildup of excess blood volume, thereby lowering the overall blood pressure. Perindopril, lisinopril, ramipril are some of the common ACE inhibitors used today. Diuretics are a group of drugs used to treat heart failure and hypertension, liver cirrhosis, and certain kidney diseases. Diuretics such as bulimics are used by patients to reduce excess weight. A drug named Metformin – a common Glucophage – is used to treat individuals with type 2 diabetes and can also prevent the onset of diabetes in people prone to similar metabolic diseases. The global cardiometabolic disease market also includes the two commercial weight loss pharmacotherapies: orlistat (Xenical) and sibutramine (Meridia).

Request for TOC of the Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=73

Patients suffering from high fat deposition are often suggested to opt for an abdominal liposuction, thereby temporarily solving the overweight issue. Apart from the therapeutic drug treatments, proponents of the global cardiometabolic disease market are also promoting the idea that consumers live a healthier lifestyle with diet and exercise.

Global Cardiometabolic Market: Regional Analysis

The global cardiometabolic disease market can be regionally segmented into North America, Europe, Asia-Pacific and the rest of the world. Of all key regions, North America held the leading share in the global cardiometabolic disease market followed by Europe, in 2016. The major factors attributed to the market’s growth in these regions are the increasing epidemic and a growing uptake of unhealthy diets and a largely sedentary lifestyle. According to a survey, so far, 32% of the population in the U.S. was affected by metabolic syndrome, 25% in Europe and Latin America, and there is a continuous rise of metabolic diseases in the developing economies of Asia Pacific. Asia Pacific is likely to be a highly lucrative market for the growth of cardiometabolic disease treatments. Furthermore, the demand for advanced and sophisticated therapeutic treatments is also likely to fuel the global cardiometabolic disease market in the coming years.

Global Cardiometabolic Market: Companies Mentioned in the Report

Some of the leading players of the global cardiometabolic disease therapeutic market for 2016 were Torrent Pharmaceutical Ltd., Cardax Pharmaceuticals, Inc., Abeille Pharmaceuticals, Inc., VivaCell Biotechnology Espana S.L., Spherix Incorporated, and Indus Biotech Private Limited.

Read Complete Report @ https://www.tmrresearch.com/cardiometabolic-disease-market

The study presents reliable qualitative and quantitative insights into:

  • Market segments and sub-segments
    Market trends and dynamics
    Supply and demand chain of the market
    Market valuation (revenue and/or volume)
    Key trends/opportunities/challenges
    Forces defining present and estimated future state of the competitive landscape
    Technological developments
    Value chain and stakeholder analysis

The regional analysis covers:

  • North America
    Latin America
    Europe
    Asia Pacific
    Middle East and Africa

The vast market research data included in the study is the result of extensive primary and secondary research activities. Surveys, personal interviews, and inputs from industry experts form the crux of primary research activities and data collected from trade journals, industry databases, and reputable paid sources form the basis of secondary research. The report also includes a detailed qualitative and quantitative analysis of the market, with the help of information collected from market participants operating across key sectors of the market value chain. A separate analysis of macro- and micro-economic aspects, regulations, and trends influencing the overall development of the market is also included in the report.

Highlights of the report:

  • A detailed analysis of key segments of the market
    Recent developments in the market’s competitive landscape
    Detailed analysis of market segments up to second or third level of segmentation
    Historical, current, and projected future valuation of the market in terms of revenue and/or volume
    Key business strategies adopted by influential market vendors
    Outline of the regulatory framework surrounding and governing numerous aspects of the market
    Growth opportunities in emerging and established markets
    Recommendations to market players to stay ahead of the competition

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Our savvy custom-built reports span a gamut of industries such as pharmaceuticals, chemicals and metals, food and beverages, and technology and media, among others. With actionable insights uncovered through in-depth research of the market, we try to bring about game-changing success for our clients.